Lucie Sancey

Grenoble, 38000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

A Zirconium Aza-BODIPY Derivative as a Near-Infrared Fluorescent/Photoacoustic Imaging Bimodal Probe.

A Zirconium Aza-BODIPY Derivative as a Near-Infrared Fluorescent/Photoacoustic Imaging Bimodal Probe.

Journal: Journal of medicinal chemistry

Published: July 06, 2026

SPECT/NIR Fluorescence Bimodal Use of Aza-BODIPY Probe Coupled with Cetuximab for Detection of Cancer: Proof of Concept on a Preclinical Head and Neck Squamous Cell Carcinoma Model.

SPECT/NIR Fluorescence Bimodal Use of Aza-BODIPY Probe Coupled with Cetuximab for Detection of Cancer: Proof of Concept on a Preclinical Head and Neck Squamous Cell Carcinoma Model.

Journal: Journal of medicinal chemistry

Published: April 21, 2026

Extended Fused Carbazole-BODIPY, High Brightness NIR Organic Dyes.

Extended Fused Carbazole-BODIPY, High Brightness NIR Organic Dyes.

Journal: Angewandte Chemie (International ed. in English)

Published: November 24, 2025

Introduction to nanomedicines for crossing biological barriers.

Introduction to nanomedicines for crossing biological barriers.

Journal: Nanoscale

Published: October 13, 2025

Comparison of the Biological Response of a Head and Neck Carcinoma and a Glioblastoma Cell Line Under Neutron Irradiation with BPA Administration.

Comparison of the Biological Response of a Head and Neck Carcinoma and a Glioblastoma Cell Line Under Neutron Irradiation with BPA Administration.

Journal: Biology

Published: July 31, 2025

The physicochemical and biochemical mechanisms of porphyrinoid-mediated radiodynamic therapy.

The physicochemical and biochemical mechanisms of porphyrinoid-mediated radiodynamic therapy.

Journal: European journal of medicinal chemistry

Published: April 03, 2025

Photodynamic drug delivery for cancer therapy: Designing liposomes for light-controlled release and enhanced drug efficacy.

Photodynamic drug delivery for cancer therapy: Designing liposomes for light-controlled release and enhanced drug efficacy.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 31, 2025

NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate.

NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate.

Journal: Journal of medicinal chemistry

Published: March 28, 2025

In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology.

In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology.

Journal: Nanoscale

Published: February 10, 2025

Conjugated Human Serum Albumin/Gold-Silica Nanoparticles as Multifunctional Carrier of a Chemotherapeutic Drug.

Conjugated Human Serum Albumin/Gold-Silica Nanoparticles as Multifunctional Carrier of a Chemotherapeutic Drug.

Journal: International journal of molecular sciences

Published: November 27, 2024

WazaGaY: An Innovative Aza-BODIPY-Derived Near-Infrared Fluorescent Probe for Enhanced Tumor Imaging.

WazaGaY: An Innovative Aza-BODIPY-Derived Near-Infrared Fluorescent Probe for Enhanced Tumor Imaging.

Journal: Journal of medicinal chemistry

Published: September 18, 2024

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma.

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 12, 2024

Showing 1-12 of 96

Last Updated: 09/26/2026